New and improved therapies to treat and protect against drug dependence and abuse are urgently needed. In the United States alone about 50 million people regularly smoke tobacco and another 5 million are addicted to other drugs. In a given year, millions of these individuals attemptâ€"with or without medical assistanceâ€"to quit using drugs, though relapse remains the norm. Furthermore, each year several million teenagers start smoking and nearly as many take illicit drugs for the first time. Research is advancing on promising new means of treating drug addiction using immunotherapies and sustained-release (depot) medications. The aim of this research is to develop medications that can block or significantly attenuate the psychoactive effects of such drugs as cocaine, nicotine, heroin, phencyclidine, and methamphetamine for weeks or months at a time. This represents a fundamentally new therapeutic approach that shows promise for treating drug addiction problems that were difficult to treat in the past. Despite their potential benefits, however, several characteristics of these new methods pose distinct behavioral, ethical, legal, and social challenges that require careful scrutiny. Such issues can be considered unique aspects of safety and efficacy that are fundamentally related to the distinct nature and properties of these new types of medications.

This open access book is a collection of research papers on COVID-19 by Germán Velásquez from 2020 and early 2021 that help to answer the question: How can an agency like the World Health Organization (WHO) be given a stronger voice to exercise authority and leadership? The considerable health, economic and social challenges that the world faced at the beginning of 2020 with COVID-19 continued and worsened in many parts of the world in the second-half of 2020 and into 2021. Many of these countries and nations wanted to explore COVID-19 on their own, sometimes without listening to the main international health bodies such as WHO, an agency of the United Nations system with long-standing experience and vast knowledge at the global level and of which all countries in the world are members. In this single volume, the chapters present the progress of thinking and debate — particularly in relation to drugs and vaccines — that would enable a response to the COVID-19 pandemic or to subsequent crises that may arise. Among the topics covered: COVID-19 Vaccines: Between Ethics, Health and Economics Medicines and Intellectual Property: 10 Years of the WHO Global Strategy Re-thinking Global and Local Manufacturing of Medical Products After COVID-19 Rethinking R&D for Pharmaceutical Products After the Novel Coronavirus COVID-19 Shock Intellectual Property and Access to Medicines and Vaccines The World Health Organization Reforms in the Time of COVID-19 Vaccines, Medicines and COVID-19: How Can WHO Be Given a Stronger Voice? is essential reading for negotiators from the 194 member countries of the World Health Organization (WHO); World Trade Organization (WTO) and World Intellectual Property Organization (WIPO) staff participating in these negotiations; academics and students of public health, medicine, health sciences, law, sociology and political science; and intergovernmental organizations and non-governmental organizations that follow the issue of access to treatments and vaccines for COVID-19.

Every week, tens of thousands of children across America are injected with the DPT (diphtheria-pertussis-tetanus) vaccine. The law requires it, and most children will get four DPT shots before they are two years old. But what if one of the components of the vaccine was not safe? What if it caused not only pain, swelling, screaming, and high fever, but also shock, convulsions, brain damage, and even death? And, to make matters worse, what if there were a safer alternative but parents didn't know about it? Wouldn't the government require the drug manufacturers to produce the safer vaccine to protect the lives of the children who might otherwise suffer the shot's crippling side effects? The answer is, unfortunately, no. A Shot in the Dark is a chilling account of just how dangerous the whole-cell pertussis vaccine (the "P" part of the DPT shot) has proven to be. It provides accurate research into the history of the vaccine's development and usage. It exposes the roles played by the FDA and drug companies. It tells the tragic stories of the young victims of the vaccine. This book is also a guide for rightfully concerned parents who are looking for answers to important questions. What are the warning signs to look for to tell if your child is likely to be sensitive to the vaccine? What should parents ask their doctors about the vaccine and their child's medical profile? What is being done, here and in other countries, to combat this frightening situation? What can parents do now to help? A Shot in the Dark is a responsible, eye-opening look at a potential problem that every parent of every young child living in this country must face. Armed with the facts in this important book, parents will be able to make informed decisions about their real medical options. Book jacket.